0
Upcoming Allied Market Research
2023
Cold Soft Capsule Market

Cold Soft Capsule Market

by Type (Gelatin based, Vegetarian capsules), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) : Global Opportunity Analysis and Industry Forecast, 2022-2032

Report Code: A50505
Pages: NA
Apr 2023 | 59 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 
Cold soft capsule is a type of medication that is commonly used by people suffering from cold and cough, also known as the common cold. This capsule typically contain a combination of active ingredients such as pain relievers, cough suppressants, and decongestants to alleviate the symptoms of cold and cough. The soft gel form of the capsule makes it easier to swallow and provides quick relief to the symptoms. 
The cold soft capsules market is expanding rapidly as a result of several factors, including rising demand for more convenient and easier-to-swallow forms of medication. Patients are looking for medication alternatives that are easy to use and do not cause discomfort or inconvenience during administration. It is soft, gel-like capsule that dissolve quickly in the stomach, allowing for rapid and efficient absorption into the bloodstream. Moreover, the growing demand for advanced delivery systems that improve the bioavailability and efficacy of the active ingredient is another important driver of this market. Innovation is also driving growth in this market, as manufacturers strive to improve delivery systems and provide better and more effective products to meet the needs of patients. The advancement in the market such as those that enable precise dosing and controlled release of the active ingredient has significantly improved the efficacy of this. 
Furthermore, the growing availability of patient data and technological advancements have resulted in an increase in demand for personalized medicine. Personalized medicine is a growing trend in healthcare because it allows for customized treatment plans that are tailored to an individual patient's unique characteristics and medical history. Personalized medicine has numerous advantages over traditional one-size-fits-all treatments, including improved efficacy, reduced side effects, and improved patient outcomes. Cold soft capsules are a popular choice for many patients because they allow for personalized dosing and targeted delivery of the active ingredient. These are designed to protect the active ingredient from degradation in the stomach's harsh environment, ensuring maximum efficacy and bioavailability. Cold soft capsules, with the ability to precisely control the release of the active ingredient, can be tailored to meet the unique needs of individual patients, resulting in more effective and efficient treatment.
As technology advances and more patient data becomes available, the trend toward personalized medicine is likely to continue. Cold soft capsules, which allow for personalized dosing and delivery of the active ingredient, are poised to play a significant role in this trend. This can help improve patient outcomes and drive market growth by providing more effective and efficient treatment thereby, creating opportunities for the upsurge in the global cold soft capsules market during the forecast period. 
 
New product launches to flourish in the market
Catalent acquired a facility in Oxfordshire in April 2022 to expand biologics capabilities in the UK and across Europe. The new facility is located south of Oxford on the world-renowned Harwell Science and Innovation Campus, which is a leading site in the UK for scientific and technological breakthroughs and home to more than 40 life science companies. Also, in January 2021 Lonza, a Swiss-based multinational corporation that provides products and services to a wide range of industries, including the pharmaceutical and healthcare industries introduced a novel new capsule solution for drug delivery in the intestine (enteric). The Capsugel Enprotect capsule does not disintegrate in the stomach and releases its contents only in the intestine. Capsugel Enprotect capsules also make the drug product manufacturing process easier by eliminating the need for extra capsule coating or sealing. Moreover, Catalent announced the launch of new OptiGel DR technology in October 2020, which helps with the creation and formulation of enteric release soft gels. The industry demand is also boosted by a variety of softgel capsule products that are entering the market with higher-quality capsule features, such as hydrophilic sandwich pills, crew caps, and duo caps. The demand for cold soft capsules has also increased as a result of the release of cold soft capsules.  
Segment Overview: 
By type: The cold soft capsules market is divided into gelatin based and vegetarian capsules. Gelatin-based cold soft capsules are the most common type of cold soft capsules and are made from animal gelatin. Vegetarian cold soft capsules, on the other hand, are made from plant-based materials and are becoming more popular as the demand for animal-free products grows. Both types of cold soft capsules have higher efficacy and bioavailability than traditional pills and liquids and are intended to meet the growing demand for more convenient and personalized forms of medication. 
 
By distribution channel: The cold soft capsules market is classified into hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies supply cold soft capsules to patients in hospitals, often as part of a treatment plan prescribed by a doctor. Retail pharmacies, including both brick-and-mortar stores and online retailers, supply cold soft capsules to patients for home use. Online pharmacies have become increasingly popular in recent years, offering a convenient and accessible way for patients to purchase cold soft capsules without having to visit a physical store. 
 
By region: Cold soft capsules are increasingly seen as a viable alternative to traditional pills and liquids by patients in the Asia-Pacific region, who are demanding more convenient forms of medication. The Asia-Pacific region's aging population is driving demand for more effective forms of medication, such as cold soft capsules. As patients seek products with improved efficacy and bioavailability, the growing middle class in countries such as China and India is driving demand for more advanced forms of medication, such as cold soft capsules. The Asia-Pacific region's growing awareness of health and wellness is driving demand for more effective forms of medication, such as cold soft capsules, which have higher efficacy and bioavailability than traditional pills and liquids. Moreover, many Asia-Pacific governments are investing in healthcare infrastructure and promoting the use of advanced forms of medication, such as cold soft capsules, which is driving the market growth.
 
Competitive analysis and profiles of the major players in the cold soft capsules market, such as AstraZeneca plc., Bayer AG, GlaxoSmithKline plc., Johnson & Johnson, Novartis AG, Pfizer Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser Group plc., Sun Pharmaceutical Industries Ltd, and The Procter & Gamble Company.
Major players have adopted product launch and acquisition as key developmental strategies to improve the product portfolio of the cold soft capsules market.  

Cold Soft Capsule Market Report Highlights

Aspects Details
By Type
  • Gelatin based
  • Vegetarian capsules
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players Johnson & Johnson, Reckitt Benckiser Group plc, GlaxoSmithKline plc, Bayer AG, AstraZeneca plc, Pfizer Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, Prestige Brands Holdings, Inc., The Procter & Gamble Company
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Cold Soft Capsule Market

Start reading.
This Report and over 19,950+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,570
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,730
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,450
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,600
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers